ORAL PRESENTATIONS: Thursday 23 June: Hepatitis C: Clinical aspects and therapy| Volume 77, SUPPLEMENT 1, S15-S16, July 01, 2022

Multicenter prospective study for the use of shortened pre-emptive therapy with Glecaprevir/Pibrentasvir (G/P) and Ezetimibe in hepatitis C (HCV) seronegative non-liver solid organ transplant recipients of HCV viremic grafts

      This paper is only available as a PDF. To read, Please Download here.